Abstract
This case report illustrates that the risk of thromboembolism in the treatment of tall girls with high dose oestrogens is not negligible.
Similar content being viewed by others
References
Blombäck M, Hall K, Ritzén EM (1983) Estrogen treatment of tall girls: risk of thrombosis? Pediatrics 72: 416–419
Breddin K, Grun H, Krzywanek HJ, schremmer WP (1975) Zur Messung der “spontanen” Thrombocytenaggregation; Plättchenaggregationstest III. Methodik. Klin Wochenschr 53: 81–89
Conte FA, Grumbach MM (1978) Estrogen use in children and adolescents: a survey. Pediatrics 62 [Suppl]: 1091–1097
Grüters A, Heidemann P, Schlüter H, Stubbe P, Weber B, Helge H (1989) Effect of different oestrogen doses on final height reduction in girls with constitutional tall stature. Eur J Pediatr 149: 11–13
Muntean W, Borkenstein M (1980) Hemostatic changes in tall girls treated with high doses of ethinylestradiol. Eur J Pediatr 134: 245–248
Petrykowski W v, Schmidt B (1983) High-dose conjugated estrogens do not reduce antithrombin III activity in tall girls. Horm Metab Res 15: 412
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Werder, E.A., Waibel, P., Sege, D. et al. Severe thrombosis during oestrogen treatment for tall stature. Eur J Pediatr 149, 389–390 (1990). https://doi.org/10.1007/BF02009654
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02009654